MONASH IVF GROUP LIMITED (MVF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MVF - MONASH IVF GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.98

23 Sep
2021

0.010

OPEN

$0.97

1.03%

HIGH

$0.98

810,088

LOW

$0.95

TARGET
$1.097 11.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . NHF . HLS . RHC . SHL . VRT . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
MVF: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 6.5 5.3 xxx
DPS (cps) xxx 4.2 3.6 xxx
EPS Growth xxx 41.8% - 18.3% xxx
DPS Growth xxx 100.0% - 15.1% xxx
PE Ratio xxx N/A 18.4 xxx
Dividend Yield xxx N/A 3.7% xxx
Div Pay Ratio(%) xxx 65.1% 67.7% xxx

Dividend yield today if purchased 3 years ago: 3.82%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.33

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/09 - 2.1c (100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx6.5
DPS All xxxxxxxxxxxxxxx4.2
Sales/Revenue xxxxxxxxxxxxxxx183.6 M
Book Value Per Share xxxxxxxxxxxxxxx68.4
Net Operating Cash Flow xxxxxxxxxxxxxxx43.3 M
Net Profit Margin xxxxxxxxxxxxxxx13.70 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Assets xxxxxxxxxxxxxxx7.07 %
Return on Equity xxxxxxxxxxxxxxx9.74 %
Return on Total Capital xxxxxxxxxxxxxxx11.16 %
Capex xxxxxxxxxxxxxxx10.0 M
Capex % of Sales xxxxxxxxxxxxxxx5.46 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx20.2 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

31/08/2021

1

Overweight

$1.10

12.24%

Industry growth for IVF continues better than Morgan Stanley anticipated though any potential normalisation is challenging to forecast. The broker prefers Monash IVF Group over Virtus Health ((VRT)) based on better near-term growth and valuation.

Australian Medicare data shows IVF cycle strength continued across the second half where fresh IVF cycles rose 45% versus the previous corresponding period. The Overweight rating is retained and the target price is increased to $1.10 from $0.90. Industry view is In-Line.

FORECAST
Morgan Stanley forecasts a full year FY22 dividend of 2.10 cents and EPS of 2.90 cents.
Morgan Stanley forecasts a full year FY23 dividend of 2.10 cents and EPS of 3.40 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

MVF STOCK CHART